Overview
Qutenza® is indicated for the management of neuropathic pain associated with postherpetic neuralgia (PHN).
A single, 1-hour, localized treatment can provide 3 months of relief from pain associated with postherpetic neuralgia (PHN). Qutenza is the first and onlyvprescription-strength capsaicin product targeted to the nerves in the skin.
Objective
Qutenza® product launch required an interactive experience so Patients and Health Care Professionals could learn about the product overview and efficacy. The interactive experience allowed users to navigate and interact with a carousel that housed product videos, facts, indications and ability to order the product.